» Articles » PMID: 2080413

[How to Evaluate the Long-term Course of Osteoarthritis. Tests for Trials of Fundamental Treatments (spine Excluded)]

Overview
Specialty Rheumatology
Date 1990 Oct 30
PMID 2080413
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The best assessment tests for long term trials on osteoarthritis (OA) of the hip and knee are the following, in order of relevance value (consensus of french experts): 1) the loss of joint space thickness on successive radiographies; 2, 3) the indices of the severity for OA of the hip and knee; the investigator's overall opinion; 4) the patient's overall opinion (visual analogue scale of handicap); 5, 6, 7) the pain level (visual analogue scale); the time for going up and down a standard flight of stairs and the time of pain in this distance; the limitation of two articular movements; 8) the increase of either analgesics or NSAIDs consumption; 9) concerning OA of fingers, the number of joints newly involved on successive radiographies. At present, only the radiological tests 1 and 9 are validated. The clinical tests 2 to 8, valuable for short term trials, have yet to be validated for long term follow-up. Recommended duration of trials is three years. A rigorous organisation is necessary to avoid erroneous inclusions: all data recorded in the pre-inclusion visit have to be checked by the principal investigator. Since we have not yet a validated chondroprotective agent as a reference drug, the trial must be randomised, double blind, placebo controlled, parallel group study.

Citing Articles

Long-term supplementation with an undenatured type-II collagen (UC-II) formulation in dogs with degenerative joint disease: Exploratory study.

Cabezas M, Benito J, Ortega A, Garcia-Pedraza E Open Vet J. 2022; 12(1):91-98.

PMID: 35342740 PMC: 8956235. DOI: 10.5455/OVJ.2022.v12.i1.11.


Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study.

Mazieres B, Hucher M, Zaim M, Garnero P Ann Rheum Dis. 2007; 66(5):639-45.

PMID: 17204566 PMC: 1954603. DOI: 10.1136/ard.2006.059899.